It's Time For a Quick Look at FactSet Research Systems's Fundamentals.

More and more people are talking about FactSet Research Systems over the last few weeks. Is it worth buying the Advertising stock at a price of $403.24? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • FactSet Research Systems has moved -8.7% over the last year

  • FDS has an average analyst rating of hold and is -5.54% away from its mean target price of $426.88 per share

  • Its trailing earnings per share (EPS) is $11.52

  • FactSet Research Systems has a trailing 12 month Price to Earnings (P/E) ratio of 35.0 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $16.41 and its forward P/E ratio is 24.6

  • The company has a Price to Book (P/B) ratio of 9.8 in contrast to the S&P 500's average ratio of 2.95

  • FactSet Research Systems is part of the Finance sector, which has an average P/E ratio of 14.34 and an average P/B of 1.57

  • FDS has reported YOY quarterly earnings growth of 18.9% and gross profit margins of 0.5%

  • The company has a free cash flow of $506,130,624.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • FactSet Research Systems Inc., a financial data and analytics company, provides integrated financial information and analytical applications to the investment community in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company delivers insight and information through the workflow solutions of research, analytics and trading, content and technology solutions, and wealth. It serves portfolio managers, investment banks, asset managers, wealth advisors, corporate clients, and other financial services entities. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.